Table 1.

Changes in Y2 receptor binding in presumed target areas of efferent projections of the CEA after Y2 gene deletion in the CEA

Brain area	% of control ± SEM
Ncl. accumbens, core	80.4 ± 5.00
Ncl. accumbens, shell	64.0 ± 4.96*
Lateral septum	87.0 ± 6.31
Stria terminalis/bed nucleus of stria terminalis	81.2 ± 3.01*
Central amygdala	62.5 ± 4.16***
Lateral hypothalamus	102.4 ± 3.88
Ventral hippocampus (CA1)	95.8 ± 3.80
Periaqueductal gray	96.6 ± 5.21
Locus ceruleus	75.2 ± 3.04*

[¹²⁵I]hPYY_3-36 was determined 4 weeks after rAAV-Cre injection (n = 16) into the CEA and compared with rAAV-GFP-injected mice (n = 10). Stringent statistical testing by ANOVA and Bonferroni post hoc test was used.

*p < 0.05,

***p < 0.001.